Predicting the Response of Patients With Rheumatoid Arthritis to Treatment With Genetically Engineered Biological Drugs and Janus (JAK) Kinase Inhibitors
Clinical trial NCT06177405 · COMPLETED
Trial details
- NCT number
- NCT06177405
- Sponsor
- Institute of Biomedical Chemistry, Russia
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-01-15
- Primary completion
- 2023-11-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.